Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
MedImmune LLC
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18 through 75 at the time of screening
Written informed consent and any locally required authorization obtained from the subject prior to performing any protocol-related procedures, including screening evaluations
History of physician-diagnosed asthma for at least 12 months prior to screening
Stable Medium- to high-dose ICS divided twice daily as outlined by the NHLBI Asthma Guidelines, 2007
You may not be if
Any medical condition that, in the opinion of the investigator or medical monitor, would interfere with interpretation of subject safety or study results
Concurrent enrollment in another clinical study
Use of immunosuppressive medication within 3 months prior to screening
Acute upper or lower respiratory infections requiring antibiotics or antiviral medications with in 30 days prior to screening or during screning period.
Receipt of immunoglobulin or blood products within 30 days prior to screening or during the screening period
Receipt of any investigational non-biological drug therapy within 30 days or 5 half-lives prior to screening whichever is longer; or receipt of any marketed or investigational biologic within 6 months or 5 half-lives prior to screening whichever is longer
Pregnant, lactating, or breastfeeding woman
Diagnosis of lung disease other than persistent asthma
History of smoking ≥10 pack years or any smoking within 12 months prior to screening
History of active, infectious hepatitis A, B, C or human immunodeficiency virus (HIV)
